| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |